Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy

Wendy L. Allen, Philip D. Dunne, Simon McDade, Enya Scanlon, Maurice Loughrey, Helen G. Coleman, Christophe McCann, Kristy McLaughlin, Zsuzsanna Nemeth, Najeeb Ashraf Syed, Puthen Veettil Jithesh, Ken Arthur, Richard Wilson, Vicky M. Coyle, Darragh McArt, Graeme L. Murray, Leslie Samuel, Paolo Nuciforo, Jose Jimenez, Guillem ArgilesRodrigo Dienstmann, Josef Tabernero, Lucia Picariello, Luca Messerini, Stefania Nobili, Enrico Mini, Kieran Sheahan, Elizabeth Ryan, Patrick G. Johnston, Sandra Van Schaeybroeck, Mark Lawler, Daniel B. Longley*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences